Synergy and interactions among biological pathways leading to preterm premature rupture of membranes

Sophia M R Lannon1, Jeroen P Vanderhoeven2, David A Eschenbach3

  • 1Department Obstetrics & Gynecology, University of Washington, Seattle, WA, USA rothbes@uw.edu.

Insights

Preterm premature rupture of membranes (PPROM) weakens fetal membranes through overlapping biological pathways. Understanding these mechanisms is crucial for reducing PPROM

Area of Science:

  • Obstetrics and Gynecology
  • Reproductive Biology
  • Perinatal Medicine

Background:

  • Preterm premature rupture of membranes (PPROM) affects 1-2% of births, with significant impact in low- and middle-income countries.
  • PPROM is a leading cause of prematurity-related mortality globally.
  • Existing research points to cytokine and matrix metalloproteinase activation, oxidative stress, and apoptosis as key pathways.

Purpose of the Study:

  • To investigate the synergistic pathways leading to PPROM.
  • To elucidate the relationship between risk factors and membrane weakening.
  • To identify future research directions for PPROM prevention.

Main Methods:

  • Review of recent investigations into PPROM.
  • Analysis of membrane composition and strength.
  • Discussion of biological pathways linking risk factors to membrane weakening.

Main Results:

  • PPROM involves complex interactions of cytokine and matrix metalloproteinase activation, oxidative stress, and apoptosis.
  • Heterogeneous etiologies like infection, placental bleeding, and genetic factors initiate these pathways.
  • These pathways are hypothesized to overlap and act synergistically to compromise membrane integrity.

Conclusions:

  • Understanding the synergistic pathways of PPROM is essential for developing targeted interventions.
  • Further research is needed to explore membrane composition, strength, and the interplay of risk factors.
  • Reducing the global burden of PPROM requires a comprehensive approach addressing its complex etiology.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
SNAREs and Membrane Fusion01:43

SNAREs and Membrane Fusion

Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
10.3K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
15.9K
Types of Membrane Protrusions01:28

Types of Membrane Protrusions

The protrusion of the cell surface is an initial step for several cellular processes, including cell migration, phagocytosis, and neurite outgrowth. These membrane protrusions are a result of cytoskeletal rearrangement. The most  widely observed cell protrusions include lamellipodia, pseudopodia, filopodia, microvilli, invadopodia, and podosomes. These protrusions can be of two types — static or dynamic.
The microvilli, an example of stable protrusions, are finger-like projections...
3.0K